Pandemic Recovery Using a COVID-Minimal Cancer Surgery Pathway

Daniel J Boffa1, Benjamin L Judson2, Kevin G Billingsley2

  • 1Smilow Cancer Hospital, Yale New Haven Hospital, New Haven, Connecticut; Department of Surgery, Yale School of Medicine, New Haven, Connecticut; Department of Neurosurgery, Yale New Haven Hospital, New Haven, Connecticut.

Insights

Hospitals can minimize COVID-19 transmission risks for surgical patients by implementing a dedicated COVID-minimal surgery pathway. This approach streamlines patient flow and resource allocation to protect vulnerable populations during the pandemic.

Area of Science:

  • Healthcare Management
  • Infectious Disease Control
  • Surgical Oncology

Background:

  • The COVID-19 pandemic significantly disrupted healthcare, leading to the curtailment of elective surgeries to prevent hospital-acquired infections.
  • Resuming elective surgeries requires managing risks for both COVID-19 and non-COVID-19 patients within healthcare settings.

Purpose of the Study:

  • To describe the development and implementation of a COVID-minimal surgery pathway for cancer patients.
  • To outline a strategy for academic medical centers to rapidly establish protocols for safe surgical care during the pandemic.

Main Methods:

  • A predetermined patient flow pathway was designed to minimize exposure risk for surgical patients.
  • The pathway dictated specific locations, personnel, and materials interacting with the cancer surgery population.
  • Implementation was achieved within 7 days at a large academic medical center.

Main Results:

  • A structured COVID-minimal surgery pathway was successfully created and implemented.
  • The pathway aimed to reduce the risk of viral transmission within the hospital environment.

Conclusions:

  • The COVID-minimal surgery pathway provides a framework for safely increasing surgical activity during the ongoing pandemic.
  • Sharing this model can assist other institutions in developing similar protocols to protect patients and align resources effectively.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
580